Topical 2% Povidone-Iodine Gel in Verruca Vulgaris

Summary

This is a multi-center, randomized, double-blind, placebo-controlled phase 2 study in subjects 8 years of age and older who present with verruca vulgaris (common warts) and desire treatment. Subjects may have up to a total of 6 common warts located on their trunk or extremities that will be treated with study medication and followed throughout the study protocol therapy. All warts will be treated two times per day (BID) for12 weeks. Approximately 90 subjects will be enrolled in this study.

Timeline

Start

2020-02-12

Primary completion

2021-01-05

Completion

2021-04

Drugs

Indications